The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Helix Biopharma Corp closed at $2.10.

Shares have lost 2.33% over the last five days, but have gained 16.67% over the last year to date. This security has outperformed the S&P TSX by 27.50% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.11
Updated October 8 3:53 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in $ millions unless otherwise notedApr 30, 201504/30/2015Jan 31, 201501/31/2015Oct 31, 201410/31/2014Jul 31, 201407/31/2014
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense2322
Selling / general / administrative1111
Research & development1111
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)------0
Other operating expenses, total--------
Operating income-2-3-2-2
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Income before tax-2-3-2-2
Income after tax-2-3-2-2
Income tax, total--0--0
Net income-2-3-2-2
Total adjustments to net income--------
Net income before extra. items-2-3-2-2
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-2-3-2-2
Inc. avail. to common incl. extra. items-2-3-2-2
Diluted net income-2-3-2-2
Dilution adjustment--------
Diluted weighted average shares78767673
Diluted EPS excluding extraordinary itemsvalue per share-0.02-0.04-0.03-0.02
Dividends per sharevalue per share0.
Diluted normalized EPSvalue per share-0.02-0.04-0.03-0.02